Supernus Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of SUPN for the last quarter is 143.64 M USD, and it's 12.58% lower compared to the previous quarter. The net income of Q1 24 is 124.00 k USD.